Skip to main content
HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiology
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiology
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Cancer
0
1
Closure Device
0
0.38
Hospital
0
0.38
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
1
Edit Tags